TIMOTHY C BARABE
CIK 1237409 · Chief Financial Officer · last filed 2026-03-12
TIMOTHY C BARABE is a Chief Financial Officer who has filed 267 SEC Form 4 insider transactions across 7 companies since 2007. The most recent filing shows the insider exercised options covering $19.2K of HTFL on Mar 12, 2026. Across all open-market trades the lifetime net is −$3.3M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $7.6M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$7.57M
7
267
-$3.29M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| HTFL | Director | 179,521 | $33.24 | $5.97M | $0 | 3 | 2026-03-12 |
| RNAC | Director | 56,966 | $9.51 | $541.7K | $301.0K | 6 | 2026-01-06 |
| Cartesian Therapeutics, Inc. (SELB) Delisted | Director | 250,013 | $0.88 | $220.3K | $273.7K | 20 | 2023-01-04 |
| VEEV | Director | 6,643 | $159.54 | $1.06M | -$1.35M | 39 | 2021-06-23 |
| Acer Therapeutics Inc. (OPXAW) Delisted | Director | 20,719 | — | — | $3.3K | 11 | 2016-11-22 |
| AFFYMETRIX INC (AFFX) Delisted | Chief Financial Officer | 166,378 | — | — | $337.8K | 21 | 2013-03-20 |
| HUMAN GENOME SCIENCES INC (HGSI) Delisted | Chief Financial Officer | 49,570 | — | — | -$2.85M | 16 | 2010-02-22 |
Recent Filings
267 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-03-12 | HTFL | Exer (M) | +8,667 | $19.2K | EDGAR |
| 2026-02-19 | HTFL | Exer (M) | +2,497 | $20.8K | EDGAR |
| 2026-01-06 | RNAC | Grant (A) | +2,600 | $0 | EDGAR |
| 2025-12-08 | RNAC | Buy (P) | +30,000 | $205.8K | EDGAR |
| 2025-08-11 | HTFL | Mixed | +131,578 | $0 | EDGAR |
| 2025-01-06 | RNAC | Grant (A) | +2,600 | $0 | EDGAR |
| 2024-08-14 | RNAC | Buy (P) | +7,500 | $95.2K | EDGAR |
| 2024-01-04 | RNAC | Grant (A) | +178,000 | $0 | EDGAR |
| 2023-11-15 | RNAC | Disp (D) | — | $0 | EDGAR |
| 2023-01-04 | Cartesian Therapeutics, Inc. (SELB) Delisted | Grant (A) | — | $0 | EDGAR |